首页> 外文期刊>Biopharmaceutics and Drug Disposition >Effect of time of dosing on the disposition of oral cibenzoline
【24h】

Effect of time of dosing on the disposition of oral cibenzoline

机译:给药时间对口服西苯唑啉处置的影响

获取原文
获取外文期刊封面目录资料

摘要

AbstractSingle oral doses of cibenzoline were administered to eight healthy volunteers on two different occasions, once at 8.00 am and once at 10.00 pm, in a randomized crossover design with at least one week separating treatments. A fast was maintained for 12 hours prior to and for 2 hours after the morning dose and the subjects did not lie down for at least 12 hours after dosing. A standard dinner was eaten 3 hours prior to the evening dose, and a fast was maintained for 10 hours after dosing; the subjects laid down 2 hours after dosing for at least 6 hours. Blood was collected at specific times for 72 hours and the total volume of urine voided was collected through 72 hours. Cibenzoline concentrations in plasma and urine were measured by HPLC. Cibenzoline absorption was slower in 7 of the 8 volunteers following the evening dose relative to the morning dose. Mean ± S.D.tmaxfor the evening dose was 2.6 ± 0.5 hours compared to 1.7 ± 0.8 for the morning dose. The corresponding mean ± S.D.Cmaxfollowing the morning dose was 446 ± 124 ng ml−1compared to 402 ± 114 ng ml−1after the evening dose. The mean ± S.D. AUC was 3328 ± 1101 ng.h.ml−1after the morning dose and 3561 ± 1430 ng.h.ml−1after the evening dose. The harmonic mean half‐life was 7.4 hours after both treatments. These data indicated that the total amount of drug absorbed and the elimination rate constant of the drug had not varied between treatments. Plasma concentrations 12 hours after the evening dose were statistically higher than those after the morning dose. The observation was consistent with the statistically higher morning trough concentrations that had been observed previously during a 12‐hour chronic dosing. There was no evidence of diurnal variation in the renal excretion of cibenzoline and the elimination half‐life and total amount of drug recovered in the urine were similar for the two times of administration. It appeared that the only pharmacokinetic difference following the morning or evening dosing was the slightly slower absorption rate at night, which should be of no
机译:摘要在两个不同的场合对8名健康志愿者给予单次口服剂量的西苯甲啉,一次在上午8:00,一次在晚上10:00,采用随机交叉设计,至少间隔一周治疗。在早上给药前和给药后 2 小时保持禁食 12 小时,受试者在给药后至少 12 小时内没有躺下。晚上给药前 3 小时吃标准晚餐,给药后禁食 10 小时;受试者在给药后 2 小时躺下至少 6 小时。在特定时间采集血液,持续 72 小时,并在 72 小时内收集排尿总量。通过HPLC测量血浆和尿液中的苯甲啉浓度。8 名志愿者中有 7 名在晚间给药后对苯甲啉的吸收速度比早上给药慢。晚间剂量的平均± S.D.tmax为2.6±0.5小时,而早晨剂量为1.7±0.8小时。早晨给药后的相应平均± S.D.Cmax为446± 124 ng ml-1,而晚间给药后为402±114 ng ml-1。平均± S.D. AUC 为 3328 ± 1101 ng.h.ml-1 后,3561 ± 1430 ng.h.ml-1 后。两次处理后的谐波平均半衰期为7.4 h。这些数据表明,药物吸收的总量和药物的消除率常数在治疗之间没有变化。晚间给药后 12 小时的血浆浓度在统计学上高于早上给药后的血浆浓度。该观察结果与先前在 12 小时慢性给药期间观察到的统计学上较高的晨谷浓度一致。没有证据表明西苯唑啉的肾脏排泄量存在昼夜变化,两次给药的消除半衰期和尿液中回收的药物总量相似。似乎早上或晚上给药后唯一的药代动力学差异是晚上吸收率稍慢,这应该没有

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号